Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mechanisms of variability in antiplatelet agents response.

Thrombosis research - 1 Oct 2012

Cattaneo Marco

Abstract excerpt

Inter-individual variability in the response to antiplatelet drugs has been reported. Suboptimal response to aspirin, as determined by specific tests, is rare and, in most instances, caused by poor compliance. In contrast, it is well established that the pharmacological response to clopidogrel is widely variable, with a significant proportion of subjects (about 1/3) being very poor responders. Inter-individual...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aspirin
Share to Biotransformation
Share to Clopidogrel

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Monitoring

Share to Platelet Aggregation

Share to Platelet Aggregation Inhibitors

Share to Platelet Function Tests

Share to Ticlopidine

Source

Identifiers

PMID: 23026654
DOI: 10.1016/j.thromres.2012.08.266

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mechanisms of variability in antiplatelet agents response.PMID 23026654Read ↗

Interindividual variability in the efficacy of oral antiplatelet drugs: definitions, mechanisms and clinical importance.Semantic proximity Read ↗

Individual variability in the disposition of and response to clopidogrel: Pharmacogenomics and beyondSemantic proximity Read ↗

Unveiling the mysteries of clopidogrel metabolism and efficacy.Semantic proximity Read ↗

Clinical, genetic and confounding factors determine the dynamics of the in vitro response/non response to clopidogrelSemantic proximity Read ↗

The Personalization of Clopidogrel Antiplatelet Therapy: The Role of Integrative Pharmacogenetics and PharmacometabolomicsSemantic proximity Read ↗

Options to overcome clopidogrel response variability.Semantic proximity Read ↗

[Clinical impact and underlying mechanism of clopidogrel response variability].Semantic proximity Read ↗

The genetic basis of platelet responsiveness to clopidogrel. A critical review of the literature.Semantic proximity Read ↗

Influence of genetic polymorphisms on platelet function, response to antiplatelet drugs and clinical outcomes in patients with coronary artery disease.Semantic proximity Read ↗

Integration of Pharmacometabolomic and Pharmacogenomic Approaches Reveals Novel Insights Into Antiplatelet TherapySemantic proximity Read ↗

Genetic causes of clopidogrel nonresponsiveness: which ones really count?Semantic proximity Read ↗

Pharmacogenetics of Clopidogrel: An Unresolved Issue.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.